← Back to Search

Social Network Interventions for Birth Control

N/A
Waitlist Available
Research Sponsored by University of California, San Diego
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, 12-month midline, and 24-month endline
Awards & highlights

Study Summary

This trial studies how social norms and networks influence Family Planning (FP) in low parity, married young women in Niger, to help USAID's Kulawa program change FP-related behaviors.

Who is the study for?
This trial is for married women aged 15-24 or their mothers-in-law living in certain villages of Niger's Maradi region, where the Kulawa FP program operates. Their husbands can also participate if they consent. Participants must agree to join discussions on family planning.Check my eligibility
What is being tested?
The study tests social strategies like 'Adopt-a-Friend', household visits, and small group discussions to see if they can improve family planning behaviors among young women by influencing social norms and networks within the community.See study design
What are the potential side effects?
Since this trial focuses on social interventions rather than medical treatments, traditional side effects are not applicable. However, participants may experience changes in personal relationships or community dynamics as a result of the intervention.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, 12-month midline, and 24-month endline
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, 12-month midline, and 24-month endline for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Contraception Use Questionnaire (individual items, not a scale)
Intentions To Use Contraception Questionnaire (individual items, not a scale)
Secondary outcome measures
Acceptance of effective contraceptive methods Questionnaire (individual items, not a scale)
Female Empowerment Questionnaire (individual items, not a scale)
Social Norms regarding gender equity Questionnaire (individual items, not a scale)

Trial Design

3Treatment groups
Experimental Treatment
Active Control
Group I: Kulawa SN (Tipping Point)Experimental Treatment3 Interventions
This arm will receive the Kulawa intervention, with a social network-informed intervention (KulawaSN) layered on top. In this arm 50% of eligible women will be paired with an alter to receive the adapted intervention. The social network intervention will involve pairing up young married adolescents and women with someone identified as influential in their social networks and enrolling them in the Kulawa FP programming together.
Group II: KulawaExperimental Treatment2 Interventions
This arm will receive the standard Kulawa intervention. Kulawa is a USAID-funded program that seeks to change FP-related behaviors among young, low parity women at scale in Niger. Kulawa, implemented by Save the Children U.S. aims to increase use of quality FP services of all WRA, including young women ages 15-24 years, in 15 districts of Niger across 3 regions (Tillaberi, Maradi, and Zinder), covering a population of 12.5 million. Kulawa will address individual, social, and health system constraints to FP use through interventions to change behavior and influence social norms that govern FP use and related gender outcomes as well as interventions to improve FP service availability and quality. Kulawa SBC programming at the community-level will include small groups for young, low parity women and girls (ages 15-24) and community dialogues.
Group III: ControlActive Control1 Intervention
This arm will serve as the control condition. Individuals in these villages will receive neither intervention (including any other FP-relevant SBC program)
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Small Groups
2016
N/A
~2900
Household Visits
2016
N/A
~2900

Find a Location

Who is running the clinical trial?

Bill and Melinda Gates FoundationOTHER
405 Previous Clinical Trials
19,626,399 Total Patients Enrolled
University of California, San DiegoLead Sponsor
1,114 Previous Clinical Trials
1,516,055 Total Patients Enrolled
Save the ChildrenOTHER
31 Previous Clinical Trials
198,571 Total Patients Enrolled

Media Library

Small Groups Clinical Trial Eligibility Overview. Trial Name: NCT05777473 — N/A
Birth Control Research Study Groups: Kulawa SN (Tipping Point), Kulawa, Control
Birth Control Clinical Trial 2023: Small Groups Highlights & Side Effects. Trial Name: NCT05777473 — N/A
Small Groups 2023 Treatment Timeline for Medical Study. Trial Name: NCT05777473 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is enrollment in this clinical research project still taking place?

"The information posted on clinicaltrials.gov reveals that this particular study is not currently seeking participants, as it was last updated in March of 2023. Nonetheless, there are 54 other ongoing studies with open enrollment at present."

Answered by AI
~637 spots leftby Dec 2024